When was Laboratoires Pharmaceutiques Trenker founded?

Laboratoires Pharmaceutiques Trenker was founded on 21 Jan 1983, making it 43 years old.

Is Laboratoires Pharmaceutiques Trenker still active?

Yes, Laboratoires Pharmaceutiques Trenker is currently active.

Where is Laboratoires Pharmaceutiques Trenker registered?

Laboratoires Pharmaceutiques Trenker's registered address is Avenue Thomas Edison 32, 1402 Nivelles, Belgium.

How many employees does Laboratoires Pharmaceutiques Trenker have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), Laboratoires Pharmaceutiques Trenker reported 88.2 full-time equivalent employees.

What is Laboratoires Pharmaceutiques Trenker's annual turnover?

Laboratoires Pharmaceutiques Trenker's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €28,950,903.

Did Laboratoires Pharmaceutiques Trenker make a profit or a loss?

Laboratoires Pharmaceutiques Trenker's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €625,092.

When did Laboratoires Pharmaceutiques Trenker last file annual accounts?

Laboratoires Pharmaceutiques Trenker's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is Laboratoires Pharmaceutiques Trenker B Corp certified?

We have no B Corp certification on file for Laboratoires Pharmaceutiques Trenker.

Does Laboratoires Pharmaceutiques Trenker hold Fairtrade certification?

No, Laboratoires Pharmaceutiques Trenker does not currently hold Fairtrade certification.

Laboratoires Pharmaceutiques Trenker

Q: What does Laboratoires Pharmaceutiques Trenker do?

Laboratoires Pharmaceutiques Trenker's registered main activities are Manufacture of medicaments, Manufacture of basic pharmaceutical products, and Wholesale of pharmaceutical and medical goods.

BE 0423.960.076

Copied!

NV/SA

Status

Active

Founded

21 Jan 1983 · 43 yrs

Size

Medium · 88.2 FTE

Legal name

S.A. Laboratoires Pharmaceutiques Trenker

Main activity

Manufacture of medicaments

Website

trenker.be

Activities

3 activities

Manufacture of medicamentsManufacture of basic pharmaceutical productsWholesale of pharmaceutical and medical goods

Financials

Turnover2025

€29M+1.7%

Profit / Loss2025

€625K+158.8%

Equity2025

€6.4M+10.9%

2025	2024	2023	2022
€28,950,903+1.7%	€28,459,252+2%	€27,889,587+2%	€27,337,154
€625,092+158.8%	€241,517-70.4%	€816,592+299.1%	-€410,251
€6,352,892+10.9%	€5,727,800-3.1%	€5,913,283+0.8%	€5,864,691
€9,701,424-11%	€10,901,292+13.7%	€9,592,154-4.4%	€10,037,845
€422,968-82%	€2,347,099+114.3%	€1,095,192+100%	€547,538
88.2-0.8%	88.9-1.8%	90.5-4.7%	95
€328,242+2.5%	€320,127+3.9%	€308,172+7.1%	€287,760

Frequently asked questions

01What is Laboratoires Pharmaceutiques Trenker's official registered name?

S.A. Laboratoires Pharmaceutiques Trenker.

02What is Laboratoires Pharmaceutiques Trenker's enterprise number (VAT number)?

BE 0423.960.076.

03What is Laboratoires Pharmaceutiques Trenker's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€28,950,903+1.7%	€28,459,252+2%	€27,889,587+2%	€27,337,154
	€8,198,503+2.2%	€8,018,950+3.9%	€7,716,899+1.4%	€7,611,901
	€912,247+18.8%	€768,081-28.1%	€1,067,627+523.9%	-€251,888
	€1,439,502+8.2%	€1,330,546-20.6%	€1,676,257+257.2%	€469,327
	€1,044,645+4.4%	€1,000,865	—	—
	€625,092+158.8%	€241,517-70.4%	€816,592+299.1%	-€410,251
	€390,136+27.6%	€305,873-5.8%	€324,559-3.2%	€335,212
Profitability
	5.0%+6.4%	4.7%-22.2%	6.0%+250.1%	1.7%
	2.2%+154.4%	0.8%-71%	2.9%+295.1%	-1.5%
	9.8%+133.4%	4.2%-69.5%	13.8%+297.4%	-7.0%
	3.9%+169.8%	1.4%-72.7%	5.3%+304.1%	-2.6%
Solvency
	€16,143,497-4.1%	€16,825,975+8.5%	€15,505,437-2.5%	€15,902,536
	€870,480-29.1%	€1,227,583-20%	€1,535,261-15.8%	€1,824,212
	€1,224,714-26.9%	€1,674,714>1000%	€34,164+16.9%	€29,214
	€6,352,892+10.9%	€5,727,800-3.1%	€5,913,283+0.8%	€5,864,691
	39.4%+15.6%	34.0%-10.7%	38.1%+3.4%	36.9%
	—	—	€495,421-54.5%	€1,089,153
	—	—	0.08-54.9%	0.19
	€9,701,424-11%	€10,901,292+13.7%	€9,592,154-4.4%	€10,037,845
	1.53-19.8%	1.90+17.3%	1.62-5.2%	1.71
	2.31+36.2%	1.70-66.1%	5.00+320.4%	-2.27
Liquidity
	€422,968-82%	€2,347,099+114.3%	€1,095,192+100%	€547,538
	€7,711,795+0.9%	€7,646,709+9.4%	€6,991,271-7.7%	€7,573,937
	€5,511,789+69.6%	€3,250,552-35.6%	€5,044,782+3.8%	€4,860,979
	€2,011,195-17%	€2,424,709-7.3%	€2,616,888-13.9%	€3,037,939
	€9,701,424-11%	€10,901,292+20%	€9,086,531+1.6%	€8,942,031
	1.40+32.4%	1.06-23.7%	1.39-6.2%	1.48
	€4,326,263+44.5%	€2,993,544-35.3%	€4,624,739-4.4%	€4,838,740
Efficiency
	69 days+66.7%	42 days-36.8%	66 days+1.7%	65 days
	37 days-13.8%	43 days-18.9%	54 days-5.6%	57 days
	296 days+18.7%	249 days-11.7%	282 days-1.5%	287 days
	1.24-18.9%	1.53+23.4%	1.24-2.4%	1.27
Profit appropriation
	—	€427,000-44.4%	€768,000	—
	€1,103,3390%	€1,103,339+2.4%	€1,077,224+3.9%	€1,036,394
	€1,573,121+65.9%	€948,029-18.2%	€1,159,627+0.7%	€1,151,865

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€28,950,903+1.7%	€28,459,252+2%	€27,889,587+2%	€27,337,154
	€8,198,503+2.2%	€8,018,950+3.9%	€7,716,899+1.4%	€7,611,901
	€912,247+18.8%	€768,081-28.1%	€1,067,627+523.9%	-€251,888
	€1,439,502+8.2%	€1,330,546-20.6%	€1,676,257+257.2%	€469,327
	€1,044,645+4.4%	€1,000,865	—	—
	€625,092+158.8%	€241,517-70.4%	€816,592+299.1%	-€410,251
	€390,136+27.6%	€305,873-5.8%	€324,559-3.2%	€335,212
Profitability
	5.0%+6.4%	4.7%-22.2%	6.0%+250.1%	1.7%
	2.2%+154.4%	0.8%-71%	2.9%+295.1%	-1.5%
	9.8%+133.4%	4.2%-69.5%	13.8%+297.4%	-7.0%
	3.9%+169.8%	1.4%-72.7%	5.3%+304.1%	-2.6%
Solvency
	€16,143,497-4.1%	€16,825,975+8.5%	€15,505,437-2.5%	€15,902,536
	€870,480-29.1%	€1,227,583-20%	€1,535,261-15.8%	€1,824,212
	€1,224,714-26.9%	€1,674,714>1000%	€34,164+16.9%	€29,214
	€6,352,892+10.9%	€5,727,800-3.1%	€5,913,283+0.8%	€5,864,691
	39.4%+15.6%	34.0%-10.7%	38.1%+3.4%	36.9%
	—	—	€495,421-54.5%	€1,089,153
	—	—	0.08-54.9%	0.19
	€9,701,424-11%	€10,901,292+13.7%	€9,592,154-4.4%	€10,037,845
	1.53-19.8%	1.90+17.3%	1.62-5.2%	1.71
	2.31+36.2%	1.70-66.1%	5.00+320.4%	-2.27
Liquidity
	€422,968-82%	€2,347,099+114.3%	€1,095,192+100%	€547,538
	€7,711,795+0.9%	€7,646,709+9.4%	€6,991,271-7.7%	€7,573,937
	€5,511,789+69.6%	€3,250,552-35.6%	€5,044,782+3.8%	€4,860,979
	€2,011,195-17%	€2,424,709-7.3%	€2,616,888-13.9%	€3,037,939
	€9,701,424-11%	€10,901,292+20%	€9,086,531+1.6%	€8,942,031
	1.40+32.4%	1.06-23.7%	1.39-6.2%	1.48
	€4,326,263+44.5%	€2,993,544-35.3%	€4,624,739-4.4%	€4,838,740
Efficiency
	69 days+66.7%	42 days-36.8%	66 days+1.7%	65 days
	37 days-13.8%	43 days-18.9%	54 days-5.6%	57 days
	296 days+18.7%	249 days-11.7%	282 days-1.5%	287 days
	1.24-18.9%	1.53+23.4%	1.24-2.4%	1.27
Profit appropriation
	—	€427,000-44.4%	€768,000	—
	€1,103,3390%	€1,103,339+2.4%	€1,077,224+3.9%	€1,036,394
	€1,573,121+65.9%	€948,029-18.2%	€1,159,627+0.7%	€1,151,865

2025

2024

2023

2022

Income statement

€28,950,903+1.7%

€28,459,252+2%

€27,889,587+2%

€27,337,154

€8,198,503+2.2%

€8,018,950+3.9%

€7,716,899+1.4%

€7,611,901

€912,247+18.8%

€768,081-28.1%

€1,067,627+523.9%

-€251,888

€1,439,502+8.2%

€1,330,546-20.6%

€1,676,257+257.2%

€469,327

€1,044,645+4.4%

€1,000,865

—

€625,092+158.8%

€241,517-70.4%

€816,592+299.1%

-€410,251

€390,136+27.6%

€305,873-5.8%

€324,559-3.2%

€335,212

Profitability

5.0%+6.4%

4.7%-22.2%

6.0%+250.1%

1.7%

2.2%+154.4%

0.8%-71%

2.9%+295.1%

-1.5%

9.8%+133.4%

4.2%-69.5%

13.8%+297.4%

-7.0%

3.9%+169.8%

1.4%-72.7%

5.3%+304.1%

-2.6%

Solvency

€16,143,497-4.1%

€16,825,975+8.5%

€15,505,437-2.5%

€15,902,536

€870,480-29.1%

€1,227,583-20%

€1,535,261-15.8%

€1,824,212

€1,224,714-26.9%

€1,674,714>1000%

€34,164+16.9%

€29,214

€6,352,892+10.9%

€5,727,800-3.1%

€5,913,283+0.8%

€5,864,691

39.4%+15.6%

34.0%-10.7%

38.1%+3.4%

36.9%

—

€495,421-54.5%

€1,089,153

—

0.08-54.9%

0.19

€9,701,424-11%

€10,901,292+13.7%

€9,592,154-4.4%

€10,037,845

1.53-19.8%

1.90+17.3%

1.62-5.2%

1.71

2.31+36.2%

1.70-66.1%

5.00+320.4%

-2.27

Liquidity

€422,968-82%

€2,347,099+114.3%

€1,095,192+100%

€547,538

€7,711,795+0.9%

€7,646,709+9.4%

€6,991,271-7.7%

€7,573,937

€5,511,789+69.6%

€3,250,552-35.6%

€5,044,782+3.8%

€4,860,979

€2,011,195-17%

€2,424,709-7.3%

€2,616,888-13.9%

€3,037,939

€9,701,424-11%

€10,901,292+20%

€9,086,531+1.6%

€8,942,031

1.40+32.4%

1.06-23.7%

1.39-6.2%

1.48

€4,326,263+44.5%

€2,993,544-35.3%

€4,624,739-4.4%

€4,838,740

Efficiency

69 days+66.7%

42 days-36.8%

66 days+1.7%

65 days

37 days-13.8%

43 days-18.9%

54 days-5.6%

57 days

296 days+18.7%

249 days-11.7%

282 days-1.5%

287 days

1.24-18.9%

1.53+23.4%

1.24-2.4%

1.27

Profit appropriation

—

€427,000-44.4%

€768,000

—

€1,103,3390%

€1,103,339+2.4%

€1,077,224+3.9%

€1,036,394

€1,573,121+65.9%

€948,029-18.2%

€1,159,627+0.7%

€1,151,865

Laboratoires Pharmaceutiques Trenker

Activities

Financials

Frequently asked questions

All locations

All locations